SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001313250-06-000043
Filing Date
2006-06-15
Accepted
2006-06-15 16:06:50
Documents
1
Group Members
CHUN R. DINGDAVID I. COHENDEREK C. SCHRIERFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL OFFSHORE INVESTORS

Document Format Files

Seq Description Document Type Size
1 osi13g.txt SC 13G 100030
  Complete submission text file 0001313250-06-000043.txt   103508
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 06907465
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 WEST TRADE STREET, SUITE 2140 CHARLOTTE NC 28202
Business Address 227 WEST TRADE STREET, SUITE 2140 CHARLOTTE NC 28202 (704)333-9192
Noonday Asset Management, L.P. (Filed by) CIK: 0001313250 (see all company filings)

IRS No.: 331106238 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G